mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci173782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Kahealani Uehara und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diabetes, Obesity, and Metabolism. Hauptthemen laut MEDLINE: Glycogen Synthase, Liver Glycogen, Mechanistic Target of Rapamycin Complex 1, Protein Phosphatase 1. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health, Novo Nordisk.
Abstract (Originalsprache)
In response to a meal, insulin drives hepatic glycogen synthesis to help regulate systemic glucose homeostasis. The mechanistic target of rapamycin complex 1 (mTORC1) is a well-established insulin target and contributes to the postprandial control of liver lipid metabolism, autophagy, and protein synthesis. However, its role in hepatic glucose metabolism is less understood. Here, we used metabolomics, isotope tracing, and mouse genetics to define a role for liver mTORC1 signaling in the control of postprandial glycolytic intermediates and glycogen deposition. We show that mTORC1 is required for glycogen synthase activity and glycogenesis. Mechanistically, hepatic mTORC1 activity promotes the feeding-dependent induction of Ppp1r3b , a gene encoding a phosphatase important for glycogen synthase activity whose polymorphisms are linked to human diabetes. Reexpression of Ppp1r3b in livers lacking mTORC1 signaling enhances glycogen synthase activity and restores postprandial glycogen content. mTORC1-dependent transcriptional control of Ppp1r3b is facilitated by FOXO1, a well characterized transcriptional regulator involved in the hepatic response to nutrient intake. Collectively, we identify a role for mTORC1 signaling in the transcriptional regulation of Ppp1r3b and the subsequent induction of postprandial hepatic glycogen synthesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Diabetes, Obesity, and Metabolism.
- Biochemistry and Molecular Biophysics Graduate Group, and.
- Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Lewis Sigler Institute for Integrative Genomics.
- Department of Chemistry, and.
- Ludwig Institute for Cancer Research, Princeton Branch, Princeton, New Jersey, USA.
Förderung
- NIDDK NIH HHS
- National Institutes of Health
- Novo Nordisk
- University of Pennsylvania
Zitieren
APA
Uehara, K., Lee, W. D., Stefkovich, M., Biswas, D., Santoleri, D., Garcia Whitlock, A., Quinn, W., Coopersmith, T., Creasy, K. T., Rader, D. J., Sakamoto, K., Rabinowitz, J. D., & Titchenell, P. M. (2024). mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b. Journal of Clinical Investigation. https://doi.org/10.1172/jci173782
Vancouver
Uehara K, Lee WD, Stefkovich M, Biswas D, Santoleri D, Garcia Whitlock A, et al. mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b. Journal of Clinical Investigation. 2024. doi:10.1172/jci173782
BibTeX
@article{Uehara2024,
author = {Uehara, Kahealani and Lee, Won Dong and Stefkovich, Megan and Biswas, Dipsikha and Santoleri, Dominic and Garcia Whitlock, Anna and Quinn, William and Coopersmith, Talia and Creasy, Kate Townsend and Rader, Daniel J and Sakamoto, Kei and Rabinowitz, Joshua D and Titchenell, Paul M},
title = {mTORC1 controls murine postprandial hepatic glycogen synthesis via Ppp1r3b},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci173782}
}
EUVIMED